730 results on '"Doshi, Peter"'
Search Results
2. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
3. Assessing Muscle-Related Adverse Events in Randomized Trials of Statins
4. Revolving doors: board memberships, hedge funds, and the FDA chiefs responsible for regulating industry
5. Covid-19 vaccine trial protocols released
6. Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
7. Covid-19 : Do many people have pre-existing immunity?
8. Covid-19 : Should doctors recommend treatments and vaccines when full data are not publicly available?
9. WHO’s malaria vaccine study represents a “serious breach of international ethical standards”
10. Development and Evaluation of a Framework for Identifying and Addressing Spin for Harms in Systematic Reviews of Interventions.
11. Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events
12. Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events
13. The FDA and Moderna’s cosy relationship: how lax rules enable a revolving door culture
14. Industry funding and self-censorship: how many bite the hand that feeds them?
15. Reporting of Drug Benefit in FDA-Approved Prescription Drug Labeling
16. Findings of an Observational Study of Neuraminidase Inhibitors Highly Sensitive to Decision to Exclude 1652 Treated Patients
17. On the ethical requirement to inform patients about potential treatment benefits
18. Letter to the editor
19. For-profit Uses of Real-World Data : What Would Frances Kelsey Do?
20. Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy
21. Sources of bias in observational studies of covid‐19 vaccine effectiveness.
22. Did the FDA break its own rules in approving the antibiotic Recarbrio?
23. Definition and rationale for placebo composition: Cross-sectional analysis of randomized trials and protocols published in high-impact medical journals
24. Sources of bias in observational studies of covid‐19 vaccine effectiveness
25. How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines
26. Visualising childhood vaccination schedules across G8 countries
27. Are manufacturers sharing data as promised?
28. No correction, no retraction, no apology, no comment : paroxetine trial reanalysis raises questions about institutional responsibility
29. 21st century cures : is US medicines bill a colossal mistake?
30. FDA drug summaries : a simplification too far?
31. No vote in US Congress on proposal to create new pathway for approving antibiotics
32. Speeding new antibiotics to market : a fake fix?
33. The evidence base for new drugs
34. Safety and Efficacy of Inactivated Influenza Vaccines in Children
35. Disclose Data Publicly, without Restriction.
36. A data driven approach for identifying AESIs
37. CDC tightens controls on scientists’ communication with news media
38. FDA to begin releasing clinical study reports in pilot programme
39. Noninferiority Trials
40. US incentive scheme for neglected diseases : a good idea gone wrong?
41. EMA policy on transparency is “strikingly” similar to deal struck with drug company, say experts
42. Digging for data on harms in duloxetine trials
43. Authors’ reply to Dunning
44. Multisystem failure : the story of anti-influenza drugs
45. Oseltamivir for influenza in adults and children : systematic review of clinical study reports and summary of regulatory comments
46. From promises to policies : is big pharma delivering on transparency?
47. Clinical trial data : get them while you can
48. The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors
49. Patient consent to publication and data sharing in industry and NIH-funded clinical trials
50. Correction to: Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.